- Home
- EQ vs QMCO Comparison
EQ vs QMCO Comparison
Compare EQ & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQ
- QMCO
- Stock Information
- Founded
- EQ 2017
- QMCO 1980
- Country
- EQ United States
- QMCO United States
- Employees
- EQ N/A
- QMCO N/A
- Industry
- EQ Biotechnology: Pharmaceutical Preparations
- QMCO Electronic Components
- Sector
- EQ Health Care
- QMCO Technology
- Exchange
- EQ Nasdaq
- QMCO Nasdaq
- Market Cap
- EQ 24.8M
- QMCO 25.4M
- IPO Year
- EQ 2018
- QMCO N/A
- Fundamental
- Price
- EQ $0.74
- QMCO $6.45
- Analyst Decision
- EQ Buy
- QMCO Hold
- Analyst Count
- EQ 2
- QMCO 2
- Target Price
- EQ $5.00
- QMCO $5.00
- AVG Volume (30 Days)
- EQ 304.3K
- QMCO 129.7K
- Earning Date
- EQ 11-13-2024
- QMCO 11-13-2024
- Dividend Yield
- EQ N/A
- QMCO N/A
- EPS Growth
- EQ N/A
- QMCO N/A
- EPS
- EQ N/A
- QMCO N/A
- Revenue
- EQ $45,914,000.00
- QMCO $285,238,000.00
- Revenue This Year
- EQ N/A
- QMCO N/A
- Revenue Next Year
- EQ N/A
- QMCO $0.11
- P/E Ratio
- EQ N/A
- QMCO N/A
- Revenue Growth
- EQ 7.70
- QMCO N/A
- 52 Week Low
- EQ $0.48
- QMCO $2.22
- 52 Week High
- EQ $3.25
- QMCO $18.00
- Technical
- Relative Strength Index (RSI)
- EQ 40.86
- QMCO 55.97
- Support Level
- EQ $0.66
- QMCO $2.88
- Resistance Level
- EQ $0.77
- QMCO $4.99
- Average True Range (ATR)
- EQ 0.08
- QMCO 0.64
- MACD
- EQ -0.01
- QMCO -0.04
- Stochastic Oscillator
- EQ 26.09
- QMCO 78.90
About EQ Equillium Inc.
Equillium Inc is a biotechnology developing therapies to treat severe autoimmune and inflammatory disorders. Its pipeline includes itolizumab, a first-in-class antibody targeting the CD6-ALCAM pathway which plays a key role in the modulation of effector T cells - currently in a Ph 3 study for patients with acute graft-versus-host disease and a Ph 1b study for patients with lupus nephritis. EQ101, a first-in-class cytokine inhibitor that selectively targets IL-2, IL-9, and IL-15 is Ph2-ready and expected to begin enrolling patients in an alopecia areata study in 2H 2022. EQ102, a cytokine inhibitor that selectively targets IL-15 and IL-21, is ready for clinical development and expected to begin enrolling patients in a Ph 1study including patients with celiac disease.
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.